Related Experiment Video
Updated: Sep 2, 2026

Inducing a Site Specific Replication Blockage in E. coli Using a Fluorescent Repressor Operator System
Published on: August 21, 2016
DNA intercalating drugs inhibit positive supercoiling induced by novobiocin in halophilic archaea
1Institute de Génétique et Microbiologie, Université Paris-Sud, CNRS, URA 1352, Orsay, France.
Abstract:
The two DNA intercalators, actinomycin D and 2-methyl-9-hydroxy-ellipticine, and the DNA minor groove ligant DAPI inhibited the growth of the haloarchaeon Halobacterium sp. GRB and bind to its plasmid pGRB-1. In contrast to specific DNA topoisomerase II inhibitors, they produced neither double-stranded breaks nor relaxation of plasmidic DNA. The two DNA intercalators inhibited positive supercoiling induced by novobiocin, suggesting that positive supercoiling in haloarchaea is due to transcription, as in the domain Bacteria. Plasmids from haloarchaea could thus be used to prescreen for DNA intercalators and to discriminate between different drug families via their mode of action.
Insights
DNA intercalators like actinomycin D and ellipticine, and DAPI, inhibit haloarchaeon growth and bind to its plasmid. These compounds offer a novel method for prescreening DNA intercalators and understanding drug actions in archaea.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Haloarchaea possess unique plasmids, such as pGRB-1 in Halobacterium sp. GRB.
- Understanding drug interactions with archaeal DNA is crucial for antimicrobial development.
- DNA topoisomerase II inhibitors are known to affect DNA structure and function.
Purpose of the Study:
- To investigate the effects of DNA intercalators and a minor groove ligand on haloarchaeal growth and plasmid DNA.
- To determine if these compounds induce DNA damage or alter supercoiling in Halobacterium sp. GRB.
- To explore the potential of haloarchaeal plasmids as a tool for drug screening.
Main Methods:
- Treatment of Halobacterium sp. GRB with actinomycin D, 2-methyl-9-hydroxy-ellipticine, and DAPI.
- Analysis of plasmid pGRB-1 for double-strand breaks and supercoiling changes.
- Assessment of growth inhibition in response to drug treatment.
Main Results:
- Actinomycin D, ellipticine, and DAPI inhibited Halobacterium sp. GRB growth and bound to plasmid pGRB-1.
- Unlike topoisomerase II inhibitors, these compounds did not cause DNA breaks or relaxation.
- DNA intercalators inhibited positive supercoiling induced by novobiocin, suggesting transcription-driven supercoiling.
Conclusions:
- Haloarchaeal plasmids can be used to prescreen for DNA intercalators.
- The mode of action of different drug families can be discriminated using haloarchaeal plasmids.
- Transcription likely drives positive supercoiling in haloarchaea, similar to Bacteria.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Drugs that Destabilize Microtubules
Nucleoid
Diversity of Archaea III
Diversity of Archaea IV
Inhibitors of Bacterial DNA Synthesis

